CORE C - ABSTRACT The purpose of the Assay Core (Core C) is to provide a common set of state-of-the-art biochemical analyses to Center researchers. The Core laboratory will provide assessments of markers of hypothalamicpituitary- adrenal axis function, neurotransmitter (central and peripheral) and drug levels for center subjects. Accurate measurement of these parameters is imperative to characterize each of the indices of early life stress, development, and their neurobiological consequences being investigated by the Center's animal and human projects. Having these determinations performed in a central facility using a common set of assay modalities will provide the unprecedented opportunity to compare these models across species (without introducing the variable of assay incompatibilities). Additionally, having a Core devoted to these analyses will guarantee high quality assay performance, allow for economies-of-scale in the purchase of assay reagents and technician time, and enable Center investigators to more fully concentrate their efforts on the unique aspects of their particular project. For Project 1, the Assay Core will provide measures of HPA axis activity, medication levels, salivary amylase &cortisol, and surveillance for substance abuse (smoking, alcohol, screening for drugs of abuse). For Project 2, the Assay Core will provide these same measures as well as measures of CRF (total and free) and CRF binding protein. This last assay will be developed by the Assay Core especially for this project. For Project 3, we will provide similar measures on the children of subjects who participate in Project 1. Measures of salivary cortisol and amylase on young children, especially infants, can be problematic. We have much experience working with Dr. Goodman's group as part of the Emory Conte Center, in obtaining these precious samples. For Project 4, we will provide measures of HPA axis activity as well as medication levels in rats. All of the data, obtained from a common set of assays, will be stored in the Assay Core's laboratory database as well as the Center's centralized WMHP relational database (refer to Core A for additional description) to be readily available to all Center investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center (P50)
Project #
5P50MH077928-05
Application #
8331603
Study Section
Special Emphasis Panel (ZMH1)
Project Start
Project End
Budget Start
2011-09-12
Budget End
2012-07-31
Support Year
5
Fiscal Year
2011
Total Cost
$232,545
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Gustafsson, Hanna C; Goodman, Sherryl H; Feng, Tianshu et al. (2018) Major depressive disorder during pregnancy: Psychiatric medications have minimal effects on the fetus and infant yet development is compromised. Dev Psychopathol 30:773-785
Di Florio, A; Putnam, K; Altemus, M et al. (2017) The impact of education, country, race and ethnicity on the self-report of postpartum depression using the Edinburgh Postnatal Depression Scale. Psychol Med 47:787-799
Putnam, Karen T; Wilcox, Marsha; Robertson-Blackmore, Emma et al. (2017) Clinical phenotypes of perinatal depression and time of symptom onset: analysis of data from an international consortium. Lancet Psychiatry 4:477-485
Neigh, Gretchen N; Nemeth, Christina L; Kelly, Sean D et al. (2017) Prenatal stress-induced increases in hippocampal von Willebrand factor expression are prevented by concurrent prenatal escitalopram. Physiol Behav 172:24-30
Knight, Anna K; Craig, Jeffrey M; Theda, Christiane et al. (2016) An epigenetic clock for gestational age at birth based on blood methylation data. Genome Biol 17:206
Johnson, Katrina C; Smith, Alicia K; Stowe, Zachary N et al. (2016) Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function. J Clin Psychiatry 77:e176-82
Lusby, Cara M; Goodman, Sherryl H; Yeung, Ellen W et al. (2016) Infant EEG and temperament negative affectivity: Coherence of vulnerabilities to mothers' perinatal depression. Dev Psychopathol 28:895-911
House, Samuel J; Tripathi, Shanti P; Knight, Bettina T et al. (2016) Obsessive-compulsive disorder in pregnancy and the postpartum period: course of illness and obstetrical outcome. Arch Womens Ment Health 19:3-10
Ehrlich, David E; Neigh, Gretchen N; Bourke, Chase H et al. (2015) Prenatal stress, regardless of concurrent escitalopram treatment, alters behavior and amygdala gene expression of adolescent female rats. Neuropharmacology 97:251-8
Postpartum Depression: Action Towards Causes and Treatment (PACT) Consortium (2015) Heterogeneity of postpartum depression: a latent class analysis. Lancet Psychiatry 2:59-67

Showing the most recent 10 out of 26 publications